Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for H0036K147 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Nantahala Capital Management, LLC
13G
|
9.7% |
8/14/2026
Event 6/30/2026
|
||
| Nantahala Capital Management, LLC | 9.7% | |||
| Wilmot B. Harkey | 9.7% | |||
| Daniel Mack | 9.7% | |||
|
TCG Crossover GP II, LLC
13G
|
9.2% |
2/17/2026
Event 10/27/2025
|
||
| TCG Crossover GP II, LLC | 9.2% | |||
| TCG Crossover Fund II, L.P. | 9.2% | |||
| Chen Yu | 9.2% | |||
|
Prosight Management, LP
13G/A
|
6.8% |
2/13/2026
Event 12/31/2025
|
||
| Prosight Management, LP | 6.8% | |||
| Prosight Fund, LP | 0.3% | |||
| Prosight Plus Fund, LP | 1.5% | |||
| Prosight Partners, LLC | 6.8% | |||
| W. Lawrence Hawkins | 6.8% | |||
| BlackRock, Inc. 13G | 5.4% |
7/27/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
|
Redmile Group, LLC
13G/A
|
9.9%
Checked 5% or less
|
4/24/2026
Event 4/20/2026
|
||
| Redmile Group, LLC | 9.9% | |||
| Jeremy C. Green | 9.9% | |||
| RedCo II Offshore SPV LLC | 6.1% | |||
| RedCo II Master Fund, L.P. | 0% | |||
|
HPWH TH AG
13G/A
|
9.6%
Checked 5% or less
|
5/19/2025
Event 5/15/2025
|
||
| HPWH TH AG | 8.5% | |||
| Dr. Hans-Peter Wild | 9.6% | |||
| Thomas Pfisterer | 0.2% | |||
|
Oaktree Capital Group Holdings GP, LLC
13G/A
|
4.1% |
11/5/2025
Event 9/30/2025
|
||
| Oaktree Fund Administration, LLC | 4.1% | |||
| Oaktree Capital Holdings, LLC | 4.1% | |||
| Oaktree Capital Group Holdings GP, LLC | 4.1% | |||
| Brookfield Asset Management ULC | 0% | |||
| Brookfield Corporation | 0% | |||
| Brookfield Asset Management, Ltd. | 0% | |||
| BAM Partners Trust | 0% | |||
|
Point72 Asset Management, L.P.
13G/A
|
4.0% |
2/17/2026
Event 12/31/2025
|
||
| Point72 Asset Management, L.P. | 4.0% | |||
| Point72 Capital Advisors, Inc. | 4.0% | |||
| Steven A. Cohen | 4.0% | |||
|
Orbimed Advisors LLC
13G/A
|
2.6% |
2/17/2026
Event 12/31/2025
|
||
| Orbimed Advisors LLC | 2.1% | |||
| Orbimed Capital LLC | 2.6% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 33.1 k | $40.3 k |
| 2026 Q2 | 118 | 93.1 M | $101 M |
| 2026 Q1 | 123 | 83.5 M | $313 M |
| 2025 Q4 | 119 | 82.9 M | $293 M |
| 2025 Q3 | 112 | 68.5 M | $274 M |
| 2025 Q2 | 93 | 68.0 M | $182 M |
| 2025 Q1 | 86 | 54.9 M | $77.3 M |
| 2024 Q4 | 88 | 56.5 M | $112 M |
| 2024 Q3 | 82 | 55.0 M | $173 M |
| 2024 Q2 | 82 | 54.8 M | $173 M |
| 2024 Q1 | 44 | 40.1 M | $180 M |
| 2023 Q4 | 42 | 36.2 M | $60.1 M |
| 2023 Q3 | 44 | 39.5 M | $35.4 M |
| 2023 Q2 | 59 | 45.4 M | $97.5 M |
| 2023 Q1 | 63 | 46.6 M | $90.9 M |
| 2022 Q4 | 66 | 38.8 M | $149 M |
| 2022 Q3 | 70 | 36.6 M | $177 M |
| 2022 Q2 | 62 | 34.5 M | $274 M |
| 2022 Q1 | 55 | 34.2 M | $502 M |
| 2021 Q4 | 63 | 33.8 M | $683 M |
| 2021 Q3 | 58 | 32.8 M | $891 M |
| 2021 Q2 | 65 | 33.5 M | $816 M |
| 2021 Q1 | 66 | 32.8 M | $801 M |
| 2020 Q4 | 57 | 32.1 M | $1.03 B |
| 2020 Q3 | 55 | 28.2 M | $922 M |
| 2020 Q2 | 43 | 21.6 M | $1.00 B |